| 查看: 1374 | 回复: 17 | |||
[交流]
开发一种新药的惊人花费（The truly staggering cost of inventing new drugs）
|
|||
|
原文链接：http://bioluminor.biomart.cn/news/2770272.htm During the Super Bowl, a representative of the pharmaceutical company Eli Lilly posted the on the company’s corporate blog that the average cost of bringing a new drug to market is $1.3 billion, a price that would buy 371 Super Bowl ads, 16 million official NFL footballs, two pro football stadiums, pay of almost all NFL football players, and every seat in every NFL stadium for six weeks in a row. This is, of course, ludicrous. The average drug developed by a major pharmaceutical company costs at least $4 billion, and it can be as much as $11 billion. The drug industry has been tossing around the $1 billion number for years. It is based largely on a study (supported by drug companies) by Joseph DiMasi of Tufts University. It’s a nice number for the pharmaceutical industry, because it seems to justify the idea that medicines should be pricey (and increasingly, they can be very pricey, costing tens of thousands of dollars per patient per year) without making it seem that inventing new medicines is so expensive an endeavor as to be ultimately futile. But as Bernard Munos of the InnoThink Center for Research In Biomedical Innovation has noted, just adjusting that estimate for current failure rates results in an estimate of $4 billion in research dollars spent for every drug that is approved. But Munos showed me another figure, where he divided each drug company’s R&D budget by the average number of drugs approved. This was far more dramatic. The range of money spent is stunning. AstraZeneca has spent $12 billion in research money for every new drug approved, as much as the top-selling medicine ever generated in annual sales; Amgen spent just $3.7 billion. At $12 billion per drug, inventing medicines is a pretty unsustainable business. At $3.7 billion, you might just be able to make money (a new medicine can probably keep generating revenue for ten years; invent one a year at that rate and you’ll do well). There are lots of expenses here. A single clinical trial can cost $100 million at the high end, and the combined cost of manufacturing and clinical testing for some drugs has added up to $1 billion. But the main expense is failure. AstraZeneca does badly by this measure because it has had so few new drugs hit the market. Eli Lilly spent roughly the same amount on R&D, but got twice as many new medicines approved over that 15 year period, and so spent just $4.5 billion per drug. Wanting to make this even more rigorous, Forbes (that would be Scott DeCarlo and me) took Munos’ count of drug approvals for the major pharmas and combined it with their research and development spending as reported in annual earnings filings going back fifteen years, pulled from a Thomson Reuters database using FactSet. We adjusted all the figures for inflation. Using both drug approvals and research budgets since 1997 keeps the estimates being skewed by short-term periods when R&D budgets or drug approvals changed dramatically. The range of money spent is stunning. AstraZeneca has spent $12 billion in research money for every new drug approved, as much as the top-selling medicine ever generated in annual sales; Amgen spent just $3.7 billion. At $12 billion per drug, inventing medicines is a pretty unsustainable business. At $3.7 billion, you might just be able to make money (a new medicine can probably keep generating revenue for ten years; invent one a year at that rate and you’ll do well). There are lots of expenses here. A single clinical trial can cost $100 million at the high end, and the combined cost of manufacturing and clinical testing for some drugs has added up to $1 billion. But the main expense is failure. AstraZeneca does badly by this measure because it has had so few new drugs hit the market. Eli Lilly spent roughly the same amount on R&D, but got twice as many new medicines approved over that 15 year period, and so spent just $4.5 billion per drug. |
回复此楼» 猜你喜欢
一志愿天中医中药学专硕，希望有b区的老师可以考虑一下我
已经有1人回复
-
调剂
已经有3人回复
-
药物学论文润色/翻译怎么收费?
已经有254人回复
-
药学学硕326求调剂
已经有0人回复
-
26年博士申请
已经有20人回复
-
药理学、临床药学方向 调剂
已经有1人回复
-
求助 苯磷硫胺JP
已经有0人回复
-
100金币 阿莫西林克拉维酸钾片BP药典中提到的克拉维酸聚合物具体结构式是啥？
已经有2人回复
-
膳食补充剂合规性交流
已经有0人回复
-
一志愿浙大药学求调剂
已经有0人回复
-
高温高压反应求助
已经有4人回复
» 抢金币啦！回帖就可以得到:
-
【招聘】温州医科大学/附属医院/瓯江实验室李校堃院士团队诚聘博士后和科研人员
+1/191
-
香港中文大学（深圳）靳羽华教授交叉实验室招募2026年材料学博士生（光致变色）
+2/122
-
香港中文大学（深圳）靳羽华教授交叉实验室高薪诚聘博士后（光致变色方向）
+2/116
-
上海电力大学先进储能电池技术课题组招生
+1/81
-
西京学院土木水利 2026 级研究生招生
+2/44
-
国家工程物理交叉科学研究中心招收凝聚态物理及相关专业硕士研究生一名
+1/42
-
招收2名土木工程方向硕士研究生
+1/37
-
【林业专业硕士调剂1名】中国林业科学研究院
+1/36
-
济南大学水利与环境学院赵艳侠教授简介
+1/32
-
春眠不觉晓
+1/19
-
双一流大学湘潭大学“化工过程模拟与强化”国家地方联合工程研究中心招收博士生
+1/17
-
【实战型】【生物医药】2026青岛大学招博士生 含少数民族骨干计划2名！
+1/17
-
电子信息求调剂
+1/10
-
【博士招生】天津理工大学国家杰青王铁课题组招收2026年博士研究生
+1/8
-
欢迎各位同学申请参加澳门大学健康科学学院的2026年夏令营，报名截止4月12号
+1/5
-
武汉纺织大学国家杰青课题组诚招调剂硕士研究生
+1/5
-
武汉理工大学船海与能源动力工程学院 刘鹏飞院士团队专任教师招聘启事
+1/5
-
南医大基础医学院招收调剂生（2生信1生物））
+1/3
-
环境微生物与污染控制研究所招收2026硕士研究生
+1/3
-
教育部重点实验室招收2026年调剂生，化学、材料、机械、计算机等
+1/1
7楼2015-08-31 16:02:44
9楼2015-09-01 08:14:29
10楼2015-09-01 08:19:15
11楼2015-09-14 11:50:36
★
小木虫: 金币+0.5, 给个红包，谢谢回帖
小木虫: 金币+0.5, 给个红包，谢谢回帖
|
本帖内容被屏蔽 |
14楼2015-09-17 14:21:15
简单回复
dmbb2楼
2015-08-31 14:57
回复
飞飞-笑笑(金币+1): 谢谢参与
2015-08-31 15:06
回复
飞飞-笑笑(金币+1): 谢谢参与
我是谁博文4楼
2015-08-31 15:15
回复
飞飞-笑笑(金币+1): 谢谢参与
2015-08-31 15:27
回复
飞飞-笑笑(金币+1): 谢谢参与
一米阳光YM6楼
2015-08-31 15:45
回复
飞飞-笑笑(金币+1): 谢谢参与
hr.wu8楼
2015-08-31 16:34
回复
fishyr12楼
2015-09-17 14:10
回复
liubopeng13楼
2015-09-17 14:11
回复
10
小白112615楼
2015-09-17 17:07
回复
1808466628316楼
2015-09-17 17:22
回复
xdon041717楼
2015-09-17 22:30
回复
William.Chen18楼
2015-09-17 23:25
回复
